title: Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response.
abstract: Herpes simplex virus type 1 (HSV-1) mutants lacking the ICP34.5 gene are severely attenuated in mouse models and have a significant growth defect in confluent mouse embryo fibroblasts. Previously, ICP34.5 was demonstrated to have a crucial role in evading the innate immune response to infection by mediating the dephosphorylation of eIF2alpha, a translation initiation factor phosphorylated by PKR during the antiviral response. To further understand the role of ICP34.5 in evasion of the antiviral response, we used transcriptional profiling to examine host cell gene expression in both wild-type and ICP34.5-null virus-infected mouse embryo fibroblasts over a time course of infection. Our study revealed that cells responded to infection within 3 h through PKR-dependent eIF2alpha phosphorylation and that the majority of up-regulated genes at 3 h postinfection were involved in the antiviral response. HSV-1 counters this response through early expression of ICP34.5 and dephosphorylation of eIF2alpha. By 12 h postinfection, the differences between the number and functional classification of genes differentially up- and down-regulated between wild-type and ICP34.5-null virus-infected cells were maximal. Specifically, in wild-type virus-infected cells, the majority of changed genes were involved in metabolic and biosynthetic processes, while in ICP34.5-null virus-infected cells, mostly antiviral genes were up-regulated. Further, ICP34.5-null virus-infected cells produced greater amounts of beta interferon than wild-type virus-infected cells. These results indicate that ICP34.5 expression and function at early times postinfection have a pivotal role in the ability of HSV-1 to gain control of the host cell and maintain an environment for successful viral replication.
authors.affiliation: Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, 660 South Euclid Ave., Box 8096, St. Louis, MO 63110, USA.
authors.forename: Tracy Jo
authors.initials: TJ
authors.lastname: Pasieka
authors.forename: Tracey
authors.initials: T
authors.lastname: Baas
authors.forename: Victoria S
authors.initials: VS
authors.lastname: Carter
authors.forename: Sean C
authors.initials: SC
authors.lastname: Proll
authors.forename: Michael G
authors.initials: MG
authors.lastname: Katze
authors.forename: David A
authors.initials: DA
authors.lastname: Leib
mesh_terms: D000818:Animals; D002522:Chlorocebus aethiops; D004622:Embryo, Mammalian / Q000166:cytology / Q000378:metabolism; D015852:Eukaryotic Initiation Factor-2 / Q000378:metabolism; D005347:Fibroblasts / Q000821:virology*; D020869:Gene Expression Profiling; D023281:Genomics; D006561:Herpes Simplex / Q000276:immunology / Q000378:metabolism / Q000821:virology; D018259:Herpesvirus 1, Human / Q000254:growth & development*; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009154:Mutation; D020411:Oligonucleotide Array Sequence Analysis; D010766:Phosphorylation; D015398:Signal Transduction; D014709:Vero Cells / Q000378:metabolism / Q000821:virology; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D014779:Virus Replication / Q000502:physiology; D019892:eIF-2 Kinase / Q000235:genetics / Q000502:physiology
chemical_list: D015852:Eukaryotic Initiation Factor-2; D014764:Viral Proteins; C066469:gamma 34.5 protein, Human herpesvirus 1; D019892:eIF-2 Kinase